News
A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant.
A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant, widely used both in Indian Ayurvedic medicine and as a traditional medicine.
Centella asiatica, also known as “gotu kola”, is native to the wetlands of Southeast Asia and belongs to the Apiaceae family; it has been used for centuries in traditional medicine because of its anti-bacterial, anti-viral, anti-hypertensive, diuretic, antiulcer and anti-inflammatory properties. The most known active compounds are asiaticoside, madecassoside, asiatic acid and madecassic acid which promote the synthesis of collagen, regulate inflammation by normalizing the hyperproliferation of keratinocytes and are able to restore the natural homeostasis of the epidermis.The monograph “Centella asiatica: entering a new era” highlights that the pre-clinical and clinical studies available, while confirming the already known properties of the plant and its traditional uses, envisages new research scenarios and broader applications, from diabetic neuropathy to cardiovascular protection, from the treatment of burns to post-partum stretch marks. These areas could open new frontiers of research and development on a plant and its properties which have been known for centuries but whose potential has still more to offer.A first important new evidence is in the cardiovascular field, where the healing properties of Centella asiatica have inspired a new concept: the extract, similarly to the modulation of keloids on skin has been proven effective on atherosclerotic plaques as well – it was shown to prevent thrombotic or embolic complications by increasing the density and stability of atherosclerotic echolucent plaques in patients with atherosclerosis.Another field where Centella asiatica may qualify for broader applications is neurology: the plant’s effectiveness for the preservation of memory and cognitive functions is already known, since it is able to prevent neuronal degeneration, especially beta-amyloid. In addition, Centella asiatica appears to have a neuroprotective effect on stroke-induced cognitive impairment and in Parkinson’s disease. Moreover, Centella asiatica is now a potential candidate for the treatment of the reduction of neurological damage induced by diabetic hyperglycemia.“Indena is happy to achieve the fulfillment of the monograph ‘Centella asiatica: entering a new era’, which envisages new fields of application for such an important extract – comments Giada Maramaldi, Business Development Manager-Personal Care at Indena –We’ve been studying Centella asiatica for years to meet the needs of several conditions, and we’ll keep developing new products to take advantage of this medicinal plant’s amazing potential”.A further new evidence about Centella asiatica’s application is related to the treatment of stretch marks, visible linear depressions of the skin secondary to fibroblast dysfunction, very frequently appearing during or after pregnancy. They may derive from alterations in the connective tissue secondary to weight gain and hormonal imbalances due to the fact that elastin, collagen and all their components from the mother’s skin and veins are conveyed to the developing fetal structures. A pilot study, aiming to assess the efficacy, safety and tolerability of a Centella asiatica containing cream applied in the postpartum period, shows that topical treatment with the cream may offer greater benefit in terms of improvement of the stretch marks.A final but not inconsequential aspect is how the Centella asiatica supply chain is managed sustainably. Indena is sensitive to the importance of careful and accurate control of all supply chains and to manage its business considering the environmental and social issues. As for the Centella asiatica, Indena is promoting social projects in one of the main harvesting areas of the plant, the Alaotra Mangoro region of Madagascar.
23 Dec 2025
From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.
Read more
19 Dec 2025
Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.
Read more
12 Dec 2025
Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.
Read more
11 Dec 2025
Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.
Read more
9 Dec 2025
With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.
Read more
8 Dec 2025
Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.
Read more
3 Dec 2025
Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.
Read more
28 Nov 2025
Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.
Read more
25 Nov 2025
Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.
Read more
24 Nov 2025
OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.
Read more